New Powder Lines for Increased Production
In response to growing demand, Hi-Tech Pharmaceuticals has introduced two additional powder lines. These lines will enhance the company’s ability to produce more of its popular Precision Protein® and support growth in its private label sector. This expansion follows earlier enhancements to the company’s tablet production capabilities.
Enhanced Tablet Production with New Presses
Earlier this year, Hi-Tech Pharmaceuticals added four new Stokes 328 tablet presses. These presses are strategically allocated to bolster the company’s production capabilities:
SLIMAGLUTIDE® and Cyclosome® Products: Two of the new presses are dedicated to producing large tablets for Hi-Tech’s Cyclosome® Technology and the revolutionary weight management product, SLIMAGLUTIDE®.
Growing OTC Market and Consumer Demand
The over-the-counter cold and flu market is substantial, with total revenue for cough and cold remedies exceeding $12 billion annually. According to Statista, this market could grow by 7% each year. The Consumer Healthcare Protection Association notes that upper respiratory treatments are the largest OTC drug category.
Hi-Tech Pharmaceuticals’ CEO, Jared Wheat, emphasized the company’s commitment to leveraging its capabilities to provide consumers with state-of-the-art products at greater savings. “Hi-Tech continues to expand its nutritional and OTC store brand products. Our supply chain management and manufacturing speed are unrivaled, making us a major producer for many top sports nutrition brands,” said Wheat.
Hi-Tech Pharmaceuticals: A Legacy of Quality and Innovation
Since its inception in 1979, Hi-Tech Pharmaceuticals has been dedicated to delivering high-quality custom manufacturing services. The company operates out of four U.S. facilities and multiple warehouses, totaling over 600,000 square feet. Before the recent expansions, Hi-Tech had the capacity to manufacture 40 billion tablets and 12 billion capsules annually. The company also boasts extensive blending, packaging, and production capabilities for various products, including beverages and nutritional supplements.
Hi-Tech Pharmaceuticals is a cGMP-certified company, committed to maintaining high standards of quality and customer service. The company’s extensive manufacturing capacity and global reach have positioned it as a leading healthcare supplier worldwide.
Comprehensive Production Capabilities
Hi-Tech Pharmaceuticals’ facilities are equipped to produce a wide range of products, including tablets, capsules, liquids, energy shots, beverages, RTDs, animal health products, and protein and pre-workout powders. The company can produce, bottle, and package a variety of beverages, such as private label water, teas, fruit juices, flavored waters, sports nutrition drinks, pre-workout drinks, liquid vitamins, protein-based products, and vitamin waters.
With high-speed shot lines capable of producing 400 shots per minute, Hi-Tech can deliver 500,000 shots per day per line. This level of production capacity ensures that Hi-Tech Pharmaceuticals can meet the diverse needs of its customers and continue to lead in the healthcare manufacturing industry.
Hi-Tech Pharmaceuticals’ recent expansions reflect its commitment to meeting growing consumer demand and maintaining its position as a leader in the pharmaceutical and nutritional supplement manufacturing industry. By enhancing its production capabilities, Hi-Tech is well-equipped to continue providing high-quality products and innovative solutions to its global customer base.
